Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1991 Mar 1;274(Pt 2):387–394. doi: 10.1042/bj2740387

Endogenous cleavage of the Arg-379-Ala-380 bond in vitronectin results in a distinct conformational change which 'buries' Ser-378, its site of phosphorylation by protein kinase A.

D Chain 1, B Korc-Grodzicki 1, T Kreizman 1, S Shaltiel 1
PMCID: PMC1150149  PMID: 1706595

Abstract

Activation of blood platelets by thrombin was previously shown to specifically release protein kinase A, which in human plasma singles out and phosphorylates one protein, identified as vitronectin. This protein is known to be involved in processes that follow platelet stimulation, specifically, in the binding of heparin (interfering with the heparin-mediated inhibition of thrombin and Factor Xa by antithrombin III), in the growth of endothelial cells and in fibrinolysis. This paper shows that phosphorylation of vitronectin by protein kinase A is stoichiometric (approx. 1 mol/mol), that it is targeted to one site (Ser-378) at the C-terminal edge of the heparin-binding domain, and that it distinguishes between the two physiologically occurring forms of vitronectin: the one-chain (75 kDa) form, and the nicked two-chain (65 + 10 kDa) form, held together by an interchain disulphide bridge. Protein kinase A phosphorylates the one-chain form but not the two-chain form, although Ser-378 and the complete recognition sequence of the kinase are still present in the clipped 65 kDa chain. Cleavage of the Arg-379-Ala-380 bond results therefore in a conformationally distinct form of vitronectin in which Ser-378 is 'buried'. This is demonstrated by our finding that Ser-378 is present in the 65 kDa chain of clipped vitronectin but inaccessible to phosphorylation at physiological pH. Upon binding heparin, the phosphorylation site becomes exposed and able to undergo a stoichiometric phosphorylation at physiological pH.

Full text

PDF
387

Images in this article

389Fig. 1.
on p.389
390Fig. 2.
on p.390
390Fig. 5.
on p.390
391Fig. 6.
on p.391
391Fig. 7.
on p.391
392Fig. 8.
on p.392

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes D. W., Reing J. E., Amos B. Heparin-binding properties of human serum spreading factor. J Biol Chem. 1985 Aug 5;260(16):9117–9122. [PubMed] [Google Scholar]
  2. Barnes D. W., Silnutzer J. Isolation of human serum spreading factor. J Biol Chem. 1983 Oct 25;258(20):12548–12552. [PubMed] [Google Scholar]
  3. Barnes D. W., Silnutzer J., See C., Shaffer M. Characterization of human serum spreading factor with monoclonal antibody. Proc Natl Acad Sci U S A. 1983 Mar;80(5):1362–1366. doi: 10.1073/pnas.80.5.1362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beavo J. A., Bechtel P. J., Krebs E. G. Preparation of homogeneous cyclic AMP-dependent protein kinase(s) and its subunits from rabbit skeletal muscle. Methods Enzymol. 1974;38:299–308. doi: 10.1016/0076-6879(74)38046-9. [DOI] [PubMed] [Google Scholar]
  5. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  6. Cohen P. Protein phosphorylation and hormone action. Proc R Soc Lond B Biol Sci. 1988 Jul 22;234(1275):115–144. doi: 10.1098/rspb.1988.0040. [DOI] [PubMed] [Google Scholar]
  7. Cooper J. A., Sefton B. M., Hunter T. Detection and quantification of phosphotyrosine in proteins. Methods Enzymol. 1983;99:387–402. doi: 10.1016/0076-6879(83)99075-4. [DOI] [PubMed] [Google Scholar]
  8. Dahlbäck B., Podack E. R. Characterization of human S protein, an inhibitor of the membrane attack complex of complement. Demonstration of a free reactive thiol group. Biochemistry. 1985 Apr 23;24(9):2368–2374. doi: 10.1021/bi00330a036. [DOI] [PubMed] [Google Scholar]
  9. Feramisco J. R., Glass D. B., Krebs E. G. Optimal spatial requirements for the location of basic residues in peptide substrates for the cyclic AMP-dependent protein kinase. J Biol Chem. 1980 May 10;255(9):4240–4245. [PubMed] [Google Scholar]
  10. Fling S. P., Gregerson D. S. Peptide and protein molecular weight determination by electrophoresis using a high-molarity tris buffer system without urea. Anal Biochem. 1986 May 15;155(1):83–88. doi: 10.1016/0003-2697(86)90228-9. [DOI] [PubMed] [Google Scholar]
  11. GROSS E., WITKOP B. Nonenzymatic cleavage of peptide bonds: the methionine residues in bovine pancreatic ribonuclease. J Biol Chem. 1962 Jun;237:1856–1860. [PubMed] [Google Scholar]
  12. Gebb C., Hayman E. G., Engvall E., Ruoslahti E. Interaction of vitronectin with collagen. J Biol Chem. 1986 Dec 15;261(35):16698–16703. [PubMed] [Google Scholar]
  13. Hayman E. G., Pierschbacher M. D., Ohgren Y., Ruoslahti E. Serum spreading factor (vitronectin) is present at the cell surface and in tissues. Proc Natl Acad Sci U S A. 1983 Jul;80(13):4003–4007. doi: 10.1073/pnas.80.13.4003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hayman E. G., Pierschbacher M. D., Ruoslahti E. Detachment of cells from culture substrate by soluble fibronectin peptides. J Cell Biol. 1985 Jun;100(6):1948–1954. doi: 10.1083/jcb.100.6.1948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hildebrand A., Schweigerer L., Teschemacher H. Characterization and identification of heparin-induced nonopioid-binding sites for beta-endorphin in human plasma. J Biol Chem. 1988 Feb 15;263(5):2436–2441. [PubMed] [Google Scholar]
  16. Ill C. R., Ruoslahti E. Association of thrombin-antithrombin III complex with vitronectin in serum. J Biol Chem. 1985 Dec 15;260(29):15610–15615. [PubMed] [Google Scholar]
  17. Izumi M., Shimo-Oka T., Morishita N., Ii I., Hayashi M. Identification of the collagen-binding domain of vitronectin using monoclonal antibodies. Cell Struct Funct. 1988 Jun;13(3):217–225. doi: 10.1247/csf.13.217. [DOI] [PubMed] [Google Scholar]
  18. Jenne D., Hugo F., Bhakdi S. Interaction of complement S-protein with thrombin-antithrombin complexes: a role for the S-protein in haemostasis. Thromb Res. 1985 May 15;38(4):401–412. doi: 10.1016/0049-3848(85)90138-0. [DOI] [PubMed] [Google Scholar]
  19. Jenne D., Stanley K. K. Molecular cloning of S-protein, a link between complement, coagulation and cell-substrate adhesion. EMBO J. 1985 Dec 1;4(12):3153–3157. doi: 10.1002/j.1460-2075.1985.tb04058.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Jenne D., Stanley K. K. Nucleotide sequence and organization of the human S-protein gene: repeating peptide motifs in the "pexin" family and a model for their evolution. Biochemistry. 1987 Oct 20;26(21):6735–6742. doi: 10.1021/bi00395a024. [DOI] [PubMed] [Google Scholar]
  21. Jiménez J. S., Kupfer A., Gani V., Shaltiel S. Salt-induced conformational changes in the catalytic subunit of adenosine cyclic 3',5'-phosphate dependent protein kinase. Use for establishing a connection between one sulfhydryl group and the gamma-P subsite in the ATP site of this subunit. Biochemistry. 1982 Mar 30;21(7):1623–1630. doi: 10.1021/bi00536a024. [DOI] [PubMed] [Google Scholar]
  22. Kemp B. E., Graves D. J., Benjamini E., Krebs E. G. Role of multiple basic residues in determining the substrate specificity of cyclic AMP-dependent protein kinase. J Biol Chem. 1977 Jul 25;252(14):4888–4894. [PubMed] [Google Scholar]
  23. Korc-Grodzicki B., Chain D., Kreizman T., Shaltiel S. An enzymatic assay for vitronectin based on its selective phosphorylation by protein kinase A. Anal Biochem. 1990 Aug 1;188(2):288–294. doi: 10.1016/0003-2697(90)90608-c. [DOI] [PubMed] [Google Scholar]
  24. Korc-Grodzicki B., Tauber-Finkelstein M., Chain D., Shaltiel S. Vitronectin is phosphorylated by a cAMP-dependent protein kinase released by activation of human platelets with thrombin. Biochem Biophys Res Commun. 1988 Dec 30;157(3):1131–1138. doi: 10.1016/s0006-291x(88)80991-4. [DOI] [PubMed] [Google Scholar]
  25. Korc-Grodzicki B., Tauber-Finkelstein M., Shaltiel S. Platelet stimulation releases a cAMP-dependent protein kinase that specifically phosphorylates a plasma protein. Proc Natl Acad Sci U S A. 1988 Oct;85(20):7541–7545. doi: 10.1073/pnas.85.20.7541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kupfer A., Gani V., Jiménez J. S., Shaltiel S. Affinity labeling of the catalytic subunit of cyclic AMP-dependent protein kinase by N alpha-tosyl-L-lysine chloromethyl ketone. Proc Natl Acad Sci U S A. 1979 Jul;76(7):3073–3077. doi: 10.1073/pnas.76.7.3073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  28. Lane D. A., Flynn A. M., Pejler G., Lindahl U., Choay J., Preissner K. Structural requirements for the neutralization of heparin-like saccharides by complement S protein/vitronectin. J Biol Chem. 1987 Dec 5;262(34):16343–16348. [PubMed] [Google Scholar]
  29. Matsudaira P. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J Biol Chem. 1987 Jul 25;262(21):10035–10038. [PubMed] [Google Scholar]
  30. McGuire E. A., Peacock M. E., Inhorn R. C., Siegel N. R., Tollefsen D. M. Phosphorylation of vitronectin by a protein kinase in human plasma. Identification of a unique phosphorylation site in the heparin-binding domain. J Biol Chem. 1988 Feb 5;263(4):1942–1945. [PubMed] [Google Scholar]
  31. Podack E. R., Dahlbäck B., Griffin J. H. Interaction of S-protein of complement with thrombin and antithrombin III during coagulation. Protection of thrombin by S-protein from antithrombin III inactivation. J Biol Chem. 1986 Jun 5;261(16):7387–7392. [PubMed] [Google Scholar]
  32. Podack E. R., Kolb W. P., Müller-Eberhard H. J. The SC5b-7 complex: formation, isolation, properties, and subunit composition. J Immunol. 1977 Dec;119(6):2024–2029. [PubMed] [Google Scholar]
  33. Podack E. R., Preissner K. T., Müller-Eberhard H. J. Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein. Acta Pathol Microbiol Immunol Scand Suppl. 1984;284:89–96. [PubMed] [Google Scholar]
  34. Preissner K. T., Anders E., Grulich-Henn J., Müller-Berghaus G. Attachment of cultured human endothelial cells is promoted by specific association with S protein (vitronectin) as well as with the ternary S protein-thrombin-antithrombin III complex. Blood. 1988 Jun;71(6):1581–1589. [PubMed] [Google Scholar]
  35. Preissner K. T., Müller-Berghaus G. Neutralization and binding of heparin by S protein/vitronectin in the inhibition of factor Xa by antithrombin III. Involvement of an inducible heparin-binding domain of S protein/vitronectin. J Biol Chem. 1987 Sep 5;262(25):12247–12253. [PubMed] [Google Scholar]
  36. Preissner K. T., Müller-Berghaus G. Neutralization and binding of heparin by S protein/vitronectin in the inhibition of factor Xa by antithrombin III. Involvement of an inducible heparin-binding domain of S protein/vitronectin. J Biol Chem. 1987 Sep 5;262(25):12247–12253. [PubMed] [Google Scholar]
  37. Preissner K. T., Müller-Berghaus G. S protein modulates the heparin-catalyzed inhibition of thrombin by antithrombin III. Evidence for a direct interaction of S protein with heparin. Eur J Biochem. 1986 May 2;156(3):645–650. doi: 10.1111/j.1432-1033.1986.tb09626.x. [DOI] [PubMed] [Google Scholar]
  38. Preissner K. T. The role of vitronectin as multifunctional regulator in the hemostatic and immune systems. Blut. 1989 Nov;59(5):419–431. doi: 10.1007/BF00349063. [DOI] [PubMed] [Google Scholar]
  39. Preissner K. T., Wassmuth R., Müller-Berghaus G. Physicochemical characterization of human S-protein and its function in the blood coagulation system. Biochem J. 1985 Oct 15;231(2):349–355. doi: 10.1042/bj2310349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Pytela R., Pierschbacher M. D., Ginsberg M. H., Plow E. F., Ruoslahti E. Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp--specific adhesion receptors. Science. 1986 Mar 28;231(4745):1559–1562. doi: 10.1126/science.2420006. [DOI] [PubMed] [Google Scholar]
  41. Ruoslahti E., Suzuki S., Hayman E. G., Ill C. R., Pierschbacher M. D. Purification and characterization of vitronectin. Methods Enzymol. 1987;144:430–437. doi: 10.1016/0076-6879(87)44192-x. [DOI] [PubMed] [Google Scholar]
  42. Shaffer M. C., Foley T. P., Barnes D. W. Quantitation of spreading factor in human biologic fluids. J Lab Clin Med. 1984 May;103(5):783–791. [PubMed] [Google Scholar]
  43. Silnutzer J. E., Barnes D. W. Effects of fibronectin-related peptides on cell spreading. In Vitro Cell Dev Biol. 1985 Jan;21(1):73–78. doi: 10.1007/BF02620918. [DOI] [PubMed] [Google Scholar]
  44. Silnutzer J., Barnes D. W. A biologically active thrombin cleavage product of human serum spreading factor. Biochem Biophys Res Commun. 1984 Jan 13;118(1):339–343. doi: 10.1016/0006-291x(84)91106-9. [DOI] [PubMed] [Google Scholar]
  45. Suzuki S., Oldberg A., Hayman E. G., Pierschbacher M. D., Ruoslahti E. Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin. EMBO J. 1985 Oct;4(10):2519–2524. doi: 10.1002/j.1460-2075.1985.tb03965.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Suzuki S., Pierschbacher M. D., Hayman E. G., Nguyen K., Ohgren Y., Ruoslahti E. Domain structure of vitronectin. Alignment of active sites. J Biol Chem. 1984 Dec 25;259(24):15307–15314. [PubMed] [Google Scholar]
  47. Thiagarajan P., Kelly K. L. Exposure of binding sites for vitronectin on platelets following stimulation. J Biol Chem. 1988 Feb 25;263(6):3035–3038. [PubMed] [Google Scholar]
  48. Tomasini B. R., Mosher D. F. Conformational states of vitronectin: preferential expression of an antigenic epitope when vitronectin is covalently and noncovalently complexed with thrombin-antithrombin III or treated with urea. Blood. 1988 Sep;72(3):903–912. [PubMed] [Google Scholar]
  49. Tomasini B. R., Owen M. C., Fenton J. W., 2nd, Mosher D. F. Conformational lability of vitronectin: induction of an antigenic change by alpha-thrombin-serpin complexes and by proteolytically modified thrombin. Biochemistry. 1989 Sep 19;28(19):7617–7623. doi: 10.1021/bi00445a017. [DOI] [PubMed] [Google Scholar]
  50. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Walsh D. A., Perkins J. P., Krebs E. G. An adenosine 3',5'-monophosphate-dependant protein kinase from rabbit skeletal muscle. J Biol Chem. 1968 Jul 10;243(13):3763–3765. [PubMed] [Google Scholar]
  52. Yatohgo T., Izumi M., Kashiwagi H., Hayashi M. Novel purification of vitronectin from human plasma by heparin affinity chromatography. Cell Struct Funct. 1988 Aug;13(4):281–292. doi: 10.1247/csf.13.281. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES